InsidersTradesSigma
Browse the full record of transactions filed by Calabrese Salvatore, 首席财务官. Insider active across 1 company, notably Gain Therapeutics, Inc.. Aggregated, 2 filings have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €23m. Activity tracked since 19 May 2022. The latest transaction was filed on 19 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Calabrese Salvatore is the Chief Financial Officer of Gain Therapeutics, Inc. He is responsible for the financial management of the company, including financial planning and risk management. His role is essential in ensuring the financial health of the company and supporting its growth initiatives.